Fig. 1: Vaccination of Syrian hamsters with ChAdOx1 nCoV-19 elicits binding and neutralizing antibodies against B.1.1.7 and B.1.351. | Nature Communications

Fig. 1: Vaccination of Syrian hamsters with ChAdOx1 nCoV-19 elicits binding and neutralizing antibodies against B.1.1.7 and B.1.351.

From: ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7

Fig. 1

a Violin plot of binding antibodies against spike protein or RBD of SARS-CoV-2 (clade A) in serum obtained 25 days post vaccination with ChAdOx1 nCoV-19. b Violin plot of virus neutralizing antibody titers against B.1.1.7 or B.1.351 in serum obtained 25 days post vaccination with ChAdOx1 nCoV-19. Statistical significance determined via Mann–Whitney test, n = 9 biologically independent animals.

Back to article page